Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia.

Disease status significantly correlated with iron status in patients with solid tumors ( P < 0.001), but not in hematological malignancies ( P = 0.172) whereas highly significant correlations between disease status and anemia could be observed in both solid tumor and hematological malignancy patients ( P < 0.001 and P < 0.001, respectively).

also in 132,142 other papers

Notably, FID was comparably prevalent (26.4%–34.4%) across all stages of hematological malignancies, whereas AID showed a trend for higher prevalence in stage IV disease (stage I–II: 5.4%, stage III: 6.2%, stage IV: 11.4%, P = 0.20).

also in 53,322 other papers